_1777294237270_124456903.png&w=64&q=75){kind=small}
Regulatory Changes to Drug Schedules in the Kingdom
The article focused on the regulatory updates approved by the joint committee between the Ministry of Health and the Saudi Food and Drug Authority to organize and classify narcotic and psychotropic substances. These provisions aim to reclassify and regulate the movement of these materials according to international standards, including defining categories for drugs and psychotropic agents, establishing a complete ban on the trade and import of certain substances, with exceptions for medications that contain small amounts of some compounds to facilitate their distribution by prescription. Additionally, all products containing cannabidiol (CBD) derived from herbal sources have been prohibited, except for those manufactured chemically and free of the psychoactive compound THC. The article also announced strict regulation of precursor chemicals and an update to the rules governing the cultivation of prohibited plants such as cannabis, coca, and poppy. These measures are intended to protect public health and regulate the legal use of psychoactive and medicinal substances within the kingdom.
Notice: This Is an AI-Generated Summary
Comments (0)